GLOBALHealthPR

As many of you across the world recently watched, the United Kingdom has elected to withdraw from the European Union following a public referendum on Thursday the 23rd of June.

It is too soon to have clear perspective on all the implications for the pharmaceutical, biotechnology and life sciences sectors, but there are several things that are already known:

• The European Medicines Agency (EMA) will be required to relocate from London, as EU agencies must be located in a Member State
• The chemistry and pharmaceutical sectors of the EU Unified Patent Court (UPC) will no longer be located in London, as previously planned

Additionally, the existing UK Medicines and Healthcare Regulatory Authority (MHRA) is likely to assume all responsibility for medicines regulation in the UK.

There are, of course, other important factors that will impact all industries, including potential trade barriers and the freedom of movement of the workforce, but it is too early to speculate on how these will play out. This is because leaving the EU will take some time.  To start the process, the UK must trigger Article 50 of the Treaty on European Union, which sets out the procedure to be followed if a Member State decides to leave.  In his resignation speech, Prime Minister David Cameron said this is a job for his successor, who he expects to be in place before the Conservative party conference in October. Once Article 50 has been triggered, negotiations to leave the EU will take place over a two-year period, during which time the implications will become clearer.

One thing that we know for certain is that the UK decision to leave the EU does not impact our GLOBALHealthPR partnership.  It is, and will continue to be, business as usual for our integrated teams across the world.

The Zika virus has been all over worldwide news recently, with U.S. researchers urging the World Health Organisation (WHO) to take action against the virus. Transmitted by the mosquito Aedes albopictus, Zika has been linked to thousands of birth defects in Brazil, and continues to spread throughout Latin America and the Caribbean.¹ But what about the effect of Zika outside the Americas? Out partners at VIVA! shared their thoughts on the potential for the virus to spread to Australia.

What about Australia?

There is genuine potential for the Zika virus to spread to Australia through travellers returning from the Americas. Fortunately, however, there is a plan of action should the outbreak occur here. Dr Cameron Webb, a clinical lecturer at the Institute of Clinical Pathology and Medical Research at the University of Sydney said, “If there was an outbreak, local health authorities would try to kill the mosquitoes and their eggs in the affected area quickly, while infected people would be isolated to limit the spread of their blood by other mosquitoes.”²

Dr Webb noted the Brazil outbreak highlighted the importance of Australia’s efforts to keep exotic mosquitoes out of the country, particularly Aedes albopictus or the Asian tiger mosquito, which is also capable of transmitting Zika.² As the climate changes and becomes warmer, there is greater potential for the Asian tiger mosquito to establish itself in cities such as Sydney and Melbourne.

Associate Professor Nigel Beebe from the University of Queensland has recently been quoted as saying “to prevent this species and others from entering Australia, there were traps designed to catch them within 400 metres of every Australian port.” When foreign species are caught in these traps, scientists are typically able to examine the species and their eggs, and determine their origin.² Scientists can then use this information to inform health, agriculture and travel authorities ²

The Department of Foreign Trade and Affairs is advising pregnant women to avoid travel in areas where Zika is active. The Federal Government is also requesting Australian doctors to look out for signs of Zika infection in travellers returning from affected areas. A government spokeswoman said Australian laboratories could diagnose the virus if required. Sydney Morning Herald, January 29, 2016.² 

What actions are being taken in your country to protect against Zika? Post a comment or tweet at us to let us know.

Want a more in depth analysis of the Zika situation in Australia? Take a look at the VIVA! blog.

References

1. Caught off-guard by Zika, Brazil struggles with deformed babies. Reuters, 28, January, 2016. Available at: http://www.reuters.com/article/us-health-zika-brazil-idUSKCN0V52F4
2. Australia, the Zika virus and why we need to keep exotic mosquitoes out. The Sydney Morning Herald, 29, January, 2016. Available at: http://www.smh.com.au/national/health/zika-virus-set-to-reach-australia-but-can-be-contained-swiftly-say-experts-20160129-gmgydw.html

As the seasons shift and the days get shorter (or longer in the Southern Hemisphere!) we look back and reflect on the successes of the past few months. One of these major successes for the GLOBALHealthPR partnership took place last May when partners from all member agencies were present in London for our Annual General Meeting (AGM). This year’s meeting, themed Reaching New Heights, was organized by our tremendous hosts at GHPR UK partner and European hub, Aurora.

For three days, partners presented case studies, analyzed client practices, brainstormed innovative ideas, and discussed creative solutions to unify the GHPR strategy. Discussions covered everything from the rollout of new initiatives to best-practice sharing sessions led by GHPR Partners. The combined efforts of this global team continues to propel GHPR to the top of its class.

Have a look inside GLOBALHealthPR and our 2015 AGM in the video above!

Today’s post comes to us from our GLOBALHealthPR Australia partner, VIVA! Communications.

Former Australian Test Cricket Captain, Steve Waugh, AO, is joining his wife and stroke survivor, Lynette, 49, health professionals and stroke survivors, to champion public awareness of stroke, its often fatal consequences, and the importance of early detection this month.

With more than 60,000 Australians experiencing stroke each year,¹ one-in-430 (17,273) of whom are from NSW,² Steve and Lynette, who survived a devastating haemorrhagic stroke in August, 2006, are urging members of the community to visit their local Blooms The Chemist pharmacy for a free Stroke Risk Assessment this Stroke Risk Awareness Month (September).

According to Steve, his wife experienced a stroke at the age of 40, without warning.

“It was completely unexpected, and an extremely intimidating and terrifying experience for everyone. “Lynette has since spent the past nine years working to reclaim her speech, memory and hearing – a battle she continues to wage today,” Steve said. “Mistakenly, many of us tend to think of stroke as an older person’s condition. But stroke can strike anyone, at any age.

“One-in-six people will have a stroke during their lifetime. While stroke currently has no cure, importantly, the most common type of stroke can be prevented,” said Steve. “Your pharmacist represents a good first port of call to determine your risk of stroke.” Stroke is one of our nation’s biggest killers,^5,6 and the second most common cause of disability in Australia.¹

“Stroke is the third most common cause of death in men, killing more men than prostate cancer, and the second most common cause of death among women, killing more women than breast cancer,”⁶ said General Practitioner, Dr Richard Kidd, Nundah Doctors, Surgery, Brisbane. There are two major types of stroke: ischaemic stroke, the most common type, responsible for four-in-five (80 per cent) strokes, that is lifestyle-preventable; and haemorrhagic stroke, responsible for one-in-five (20 per cent) strokes.³

Risk factors for stroke include older age, gender, family history, medical conditions and lifestyle. Lifestyle factors that increase the risk of stroke include high blood pressure, high cholesterol, obesity, cigarette smoking, poor diet and exercise, and high alcohol consumption. “While certain stroke risk factors cannot be controlled, lifestyle risk factors for stroke can,” Dr Kidd said. “With the help of your family doctor and pharmacist, you can reduce your risk of stroke by reducing high blood pressure, quitting smoking, reducing excess weight, achieving good control of diabetes and reducing excessive alcohol. A significant family history may indicate investigation for less common risk factors. A healthy diet, regular physical activity, screening for stroke risk and regular visits to your doctor and pharmacist, are all measures that help prevent stroke.”^7,8

“I have no family history of stroke. I don’t smoke, and I’m not a big drinker. My stroke just happened,” explained the former Australian Test Cricket Captain’s wife, Lynette, who considers herself very fortunate to have survived stroke.  “It [stroke] was an unusual experience that left me cocooned. I didn’t understand why I was in hospital. I didn’t even know I’d had surgery on my head.” Lynette cites her biggest frustration with stroke has been its effect on her immediate family. “A stroke is sudden and abrupt to the blood supply to the brain, and that’s how it affects the family as well. It’s sudden and abrupt to a family.”

Reflecting on the arduous, ongoing recovery process from stroke, Lynette advises “It’s important not to be in a hurry when recovering from stroke. The re-learning process is ongoing. It’s something you need to keep working on every day.

“I was in speech therapy twice-a-week and had daily activities to complete. I had to learn to talk all over again,” said Lynette. As a stroke survivor, Lynette contends she is well-positioned to campaign for heightened public awareness of stroke and its often devastating consequences. “My message to the public is to be aware of stroke, to not ignore any potential signs of stroke, and if present, to jot these signs down.

“Having a Stroke Risk Assessment is an initial step toward stroke prevention,” Lynette said.  According to Kurt Smith, Working Partner and Pharmacist, Blooms The Chemist, Wyong, NSW, an ischaemic stroke can be prevented by addressing simple lifestyle factors through this type of assessment.^7,8

“A Stroke Risk Assessment takes less than 10 minutes. It involves a pharmacist taking your blood pressure and asking a series of simple questions designed to assess your overall risk of stroke. Should the pharmacist consider you to be at-risk of stroke, you will be advised to seek prompt medical advice,” Kurt said. “The results will be feature in a Doctor referral form for the patient to share with their doctor.”

Social media manager, Deb, 53, Sydney, lost her mother, Sylvia, 70, in July this year, following four ischemic strokes over the past four years.

The heavy smoker, mother-of-three and grandmother-to-four, lost her ability to walk and talk, her independence and eventually, her ability to care for herself. After her third stroke last year, her husband, Edward, became her full-time carer.

“It was hard for Mum because, eventually, she couldn’t even make a cup of coffee, feed herself, get dressed, go to the toilet or have a shower,” said Deb. “Mum was in and out of hospital after her second stroke, until she passed away. It was devastating to see what stroke can do to a loved one.

“A Stroke Risk Assessment could have prevented Mum’s stroke, and had I known they existed at the time, I would have encouraged her to have had one, because stroke prevention is key,” Deb said. “Dealing with stroke and the impact it has on the individual and their family, is heart-wrenching. I would urge anyone to undergo a simple Stroke Risk Assessment to help prevent the devastation that results from stroke,” she said.

About stroke

Stroke is a medical emergency that can lead to brain damage or even death.^9,10 Stroke occurs when blood flow to the brain is interrupted, either by a blockage in an artery, or a bleed in the brain.¹¹ Interrupted blood flow stops nutrients and oxygen reaching affected parts of the brain, resulting in brain cell death in those areas.⁹

If you suspect you, a family member or friend is at-risk of stroke, visit your local Blooms The Chemist pharmacist for a Stroke Risk Assessment this Stroke Risk Awareness Month. Stroke Risk Assessments are being run throughout major metropolitan and regional areas of NSW, QLD and in Melbourne. For further information, head to http://www.blooms.net.au/monitoring-management/.     

———————————————————————————————————————————————–

References

1. Neuroscience Research Australia. Stroke. Available at: https://www.neura.edu.au/health/stroke [last accessed August 2015].
2. Stroke Foundation Australia. Stroke in Australia – No postcode untouched, 2014. Available at: https://strokefoundation.com.au/~/media/strokewebsite/resources/research/nsf952_nopostcodeuntouched_web2.ashx?la=en [last accessed August, 2015].
3. Stroke Foundation Australia. About stroke. Available at https://strokefoundation.com.au/about-stroke/types-of-stroke [last accessed August, 2015].
4. Stroke Foundation Australia. Preventing stroke: Available at: https://strokefoundation.com.au/about-stroke/preventing-stroke [last accessed August, 2015].
5. Australian Institute of Health & Welfare. Leading Causes of Death. Available at: http://www.aihw.gov.au/deaths/leading-causes-of-death/ [last accessed August, 2015].
6. Australian Institute of Health and Welfare 2012. Australia’s Health 2012. Available at http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737422169 [last accessed July, 2015].
7. Health Direct Australia. What causes a stroke. Available at: http://www.healthdirect.gov.au/what-causes-a-stroke [last accessed August, 2015].
8. Stroke Foundation Australia. Stroke risk factors. Available at: https://strokefoundation.com.au/about-stroke/preventing-stroke/stroke-risk-factors [last accessed August, 2015].
9. Health Direct Australia. Stroke. Available at: http://www.healthdirect.gov.au/stroke [last accessed August, 2015].
10. Better Health Channel. Stroke. Available at: http://www.betterhealth.vic.gov.au/bhcv2/bhcarticles.nsf/pages/stroke [last accessed August, 2015].
11. Stroke Foundation Australia. What is a stroke. Available at: https://strokefoundation.com.au [last accessed August, 2015].

What factors do you consider when selecting a doctor? In Australia as in other countries, payment is a hot topic of discussion. Today’s post comes to us from our GLOBALHealthPR Australia partner, VIVA! Communications.

In Australia, patients may soon begin to see higher bills each time they visit their local doctors as the government has chosen to freeze Medicare rebates for general practitioner (GP) services. This move is expected to generate approximately $1.3 billion in government savings that would otherwise have been directed to GPs by 2018.

In preparing to launch an extensive Medicare review after ruling out a Medicare co-payment, The Federal Health Minister, The Hon. Sussan Ley MP, was reported by The Sydney Morning Herald on April 22, 2015 to have said, “Basically, there’s wide agreement the Medicare system in its current form, is sluggish, bloated and at high risk of long-term chronic problems, and continuing to patch it up with band-aids won’t fix it.”

This brings about a larger question about how co-payments fit into the broader set of considerations that patients must address when selecting a provider.

GPs have warned the ongoing freeze on Medicare fees may attract an additional $8.43 co-payment for non-concession patients by 2018, which is all the more reason why Australians should be asking their GPs if their billing processes are changing.

Factors to consider when selecting a doctor:

If you’re on the hunt for a new general practitioner (GP), there are certain items you need to take into account, including gender, age, availability, qualifications and specialisation, other service provisions and of course, billing.

Associate Professor Helena Britt from The University of Sydney’s Family Medicine Research Centre was reported by The Age on June 16, 2015 to have said age and gender are important considerations in GP selection.

“Female GPs are more likely to conduct longer consultations and ask about psycho-social issues, and some male GPs avoid offering procedures such as pap smears for women altogether.”

Furthermore, older GPs are known to rely more on clinical experience and patient examinations, while younger GPs order more tests to verify their suspicions.

Importantly, you need to be able to establish a connection with your doctor and to be able to engage in open, honest dialogue.

Availability is also critical. On what basis does your GP work, and can you afford to wait? Large corporate clinics tend to operate after-hours and cater to walk-ins, but may involve longer waiting times. On the flip side, small, family-oriented GP practices are open during business hours and offer a more personalised service.

It’s also important to consider a GP’s area of specialisation in order to best meet your healthcare needs. For instance, does your GP specialise in women’s, men’s or sexual health, pediatrics, obstetrics, dermatology, travel medicine, addictions, complementary medicine, or other therapeutic areas?

Furthermore, what other services does your GP offer (e.g. pathology, diagnostic imaging) and are they conveniently located (i.e. in-house, next door, down the road)? In addition, does your GP practice house allied health professionals, such as physiotherapists, psychologists, dieticians and nutritionists?

Perhaps a locum doctor service (such as the Home Doctor Service and Australian Locum Medical Service) is more suited to your healthcare needs? These bulk-billed services operate from 4pm to 8am, seven days a week, with an average waiting time of up to three hours, and cater for sickness that does not warrant hospital attention.

Recently, Ley has vocalized that her views on GP services in general remain the same. She shared her opinions with The Sydney Morning Herald on August 4, 2015, “We are committed to finding better ways to care for people with chronic and complex conditions and ensure they receive the right care, in the right place, at the right time.” Ley agrees with the public that the Medicare system is not supportive enough of chronic and complex health conditions.

So remember to think twice when selecting your GP.

Interested in more details regarding the Australian government’s freeze on indexation of Medicare rebates to GPs? Head over the VIVA! blog for a more in-depth look.

 

 

 

There’s no better feeling when you run a client services agency than to identify a need and be able to deliver a solution. We get to do that today, with the introduction of Reimbursography, GLOBALHealthPR’s global strategic communications programme that leverages country-specific access insights to shape the value context for reimbursement success.

GLOBALHealthPR clients discover some of the world’s most innovative treatments for life-threatening conditions, saving and improving lives around the globe. They invest billions of dollars in the science and in the people who develop treatments for cancer, infectious and cardiovascular diseases, and more. Yet when their drugs make it through regulatory approvals, they face huge hurdles in global market access and reimbursement. A treatment’s value to the patient, to the community, to the healthcare system as a whole, is reduced to a discussion – usually an overwhelmingly contentious one – about the cost of the prescription.

But price is not really the issue here. It’s about recognition – by all decision makers – of the value that a new treatment brings to the market. To achieve that recognition, you need to build and tell a compelling and credible value story.

In our inaugural Reimbursography white paper, “Pharma Market Access Success: Shifting the Dialogue from Price to Value Through Strategic Communications,” we demonstrate how communications creates the right environment for value recognition.

Market Demand for a New Approach

At GLOBALHealthPR we see an opportunity to redefine market access communications, building the story early in the drug development process and sustaining it throughout the product lifecycle. Clients have increasingly turned to us for help with market access challenges. In the countries where we live and work, GLOBALHealthPR partners have seen restrictions attached to reimbursement agreements and reluctance of companies to even launch a product in some markets. Reimbursography reflects our collective capabilities to substantiate and communicate the value of an innovative treatment for funding, access, coverage and reimbursement in markets around the world.

 

What Makes GLOBALHealthPR Stand Out When it Comes to Market Access Communications

• We are a connected global network that works effectively and efficiently in key geographies around the world. Check out our high-level market access and reimbursement insights for key markets in our Reimbursography guides.
• Our partnership includes expertise in health communications, PhD scientists, best-in-class market access consultants and trusted counselors with in-country experience and relationship
• We engage clients to conduct a value analysis and bring together company cross-functional leaders and key market access stakeholders for an open dialog about value, to ultimately arrive at a customised value communications playbook.

Download the white paper and get in touch with GLOBALHealthPR to learn how Reimbursography can help tell your product’s story to showcase its value to the marketplace.